Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Cervix carcinoma--Austrian Vaccination Committee recommends HPV vaccination].

× No keyword cloud information.

13 in total

Review 1. Management of anogenital warts (condylomata acuminata).

Authors: G von Krogh
Journal: Eur J Dermatol Date: 2001 Nov-Dec Impact factor: 3.328

Review 2. Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia.

Authors: Elmar A Joura
Journal: Curr Opin Obstet Gynecol Date: 2002-02 Impact factor: 1.927

3. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors: J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal: J Pathol Date: 1999-09 Impact factor: 7.996

Review 4. Epidemiology of genital human papillomavirus infection.

Authors: L Koutsky
Journal: Am J Med Date: 1997-05-05 Impact factor: 4.965

5. A population-based study of squamous cell vaginal cancer: HPV and cofactors.

Authors: Janet R Daling; Margaret M Madeleine; Stephen M Schwartz; Katherine A Shera; Joseph J Carter; Barbara McKnight; Peggy L Porter; Denise A Galloway; James K McDougall; Hisham Tamimi
Journal: Gynecol Oncol Date: 2002-02 Impact factor: 5.482

6. Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population.

Authors: K Syrjänen; M Hakama; S Saarikoski; M Väyrynen; M Yliskoski; S Syrjänen; V Kataja; O Castrén
Journal: Sex Transm Dis Date: 1990 Jan-Mar Impact factor: 2.830

7. Vulvar intraepithelial neoplasia III: a viral disease of undetermined progressive potential.

Authors: U Hørding; J Junge; H Poulsen; F Lundvall
Journal: Gynecol Oncol Date: 1995-02 Impact factor: 5.482

8. Multifocal vulvar intraepithelial neoplasia grade III and multicentric lower genital tract neoplasia is associated with transcriptionally active human papillomavirus.

Authors: M van Beurden; F J ten Kate; H L Smits; R J Berkhout; A J de Craen; N van der Vange; F B Lammes; J ter Schegget
Journal: Cancer Date: 1995-06-15 Impact factor: 6.860

9. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up.

Authors: L L Villa; R L R Costa; C A Petta; R P Andrade; J Paavonen; O-E Iversen; S-E Olsson; J Høye; M Steinwall; G Riis-Johannessen; A Andersson-Ellstrom; K Elfgren; G von Krogh; M Lehtinen; C Malm; G M Tamms; K Giacoletti; L Lupinacci; R Railkar; F J Taddeo; J Bryan; M T Esser; H L Sings; A J Saah; E Barr
Journal: Br J Cancer Date: 2006-11-21 Impact factor: 7.640

10. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis.

Authors: G M Clifford; J S Smith; M Plummer; N Muñoz; S Franceschi
Journal: Br J Cancer Date: 2003-01-13 Impact factor: 7.640